Visual Function and Exercise in Glaucoma Patients

September 10, 2026 updated by: Xiaodong Sun, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Exploring the Relationship Between Visual Function and Exercise in Patients With Glaucoma

This study will investigate the relationship between visual function-including central visual field, the retinal nerve fiber layer (RNFL) in the macular and optic disc regions, intraocular pressure, and other factors-and exercise in patients with glaucoma. It aims to explore whether exercise has a protective effect on visual function in glaucoma patients and to provide recommendations for the clinical care of these patients.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
      • Shanghai, China, 200080
        • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

glaucoma patients in Shanghai General Hospital

Description

Inclusion Criteria:

  • 18-100 years male or female glaucoma patients
  • Complete the sports questionnaire

Exclusion Criteria:

  • diseases that cause less than 5 years survival;
  • condition that causes low compliance, for instance cognition disorder;
  • Any eye with disease that would interfere with the examinations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
questionnaire
Other: answer questionnaire
All patients enrolled in the cohort are required to complete a questionnaire.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
central visual field
Time Frame: month 3
month 3

Secondary Outcome Measures

Outcome Measure
Time Frame
retinal nerve fiber layer (RNFL) in the macular regions
Time Frame: month 3
month 3
retinal nerve fiber layer (RNFL) in the optic disc regions
Time Frame: month 3
month 3
intraocular pressure
Time Frame: month 3
month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Investigators

  • Principal Investigator: Xiaodong Sun, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 30, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

September 10, 2026

First Submitted That Met QC Criteria

September 10, 2026

First Posted (Actual)

September 17, 2026

Study Record Updates

Last Update Posted (Actual)

September 17, 2026

Last Update Submitted That Met QC Criteria

September 10, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ZGR202609

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe